HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The utility of reverse phenotyping: a case of lysinuric protein intolerance presented with childhood osteoporosis.

AbstractOBJECTIVES:
Childhood osteoporosis is often a consequence of a chronic disease or its treatment. Lysinuric protein intolerance (LPI), a rare secondary cause of the osteoporosis, is an autosomal recessive disorder with clinical features ranging from minimal protein intolerance to severe multisystemic involvement. We report a case diagnosed to have LPI using a Next Generation Sequencing (NGS) panel and evaluate the utility of reverse phenotyping.
CASE PRESENTATION:
A fifteen-year-old-boy with an initial diagnosis of osteogenesis imperfecta, was referred due to a number of atypical findings accompanying to osteoporosis such as splenomegaly and bicytopenia. A NGS panel (TruSight One Sequencing Panel) was performed and a novel homozygous mutation of c.257G>A (p.Gly86Glu) in the SLC7A7 gene (NM_001126106.2), responsible for LPI, was detected. The diagnosis was confirmed via reverse phenotyping.
CONCLUSIONS:
Reverse phenotyping using a multigene panel shortens the diagnostic process.
AuthorsEnise Avci Durmusalioglu, Esra Isik, Durdugul Ayyildiz Emecen, Damla Goksen, Samim Ozen, Huseyin Onay, Melis Kose, Tahir Atik, Sukran Darcan, Ozgur Cogulu, Ferda Ozkinay
JournalJournal of pediatric endocrinology & metabolism : JPEM (J Pediatr Endocrinol Metab) Vol. 34 Issue 7 Pg. 957-960 (Jul 27 2021) ISSN: 2191-0251 [Electronic] Germany
PMID33823103 (Publication Type: Case Reports)
Copyright© 2021 Walter de Gruyter GmbH, Berlin/Boston.
Chemical References
  • Amino Acid Transport System y+L
  • SLC7A7 protein, human
Topics
  • Adolescent
  • Amino Acid Metabolism, Inborn Errors (complications, genetics)
  • Amino Acid Transport System y+L (genetics)
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Male
  • Osteogenesis Imperfecta (genetics)
  • Osteoporosis (etiology)
  • Phenotype

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: